CASE REPORT
A 32-year-old female presented with progressive vision deterioration for the last 18 months the present status of vision being 20/40(best corrected in both eyes).
General examination and systemic examination were unremarkable. On examination best corrected visual acuity was 20/40 in both eyes, with normal anterior segment examination.
On fundus examination, the posterior pole showed an area of well-delineated chorioretinal degeneration with hyperpigmentation at the border of the lesion. A central crater-like lesion affecting all retinal layers, as well as the deep choroidal tissue, was seen. A provisional diagnosis of North Carolina Macular Dystrophy was made.
North Carolina Macular Dystrophy DISEASE entity
North Carolina macular dystrophy is a congenital, autosomal dominant, non-progressive macular maldevelopment. It is named after a family in North Carolina, who was reported 50 years ago, with congenital, non-progressive macular dystrophy.
These findings were first described by Leffler, Wadsworth, and Sid bury. The disease is believed to progress till the age of 12 years. After the age of 12, the disease rarely progresses.
The Macula is an important part of the eye, located in the center of the retina, and provides the sharpest vision. NCMD is a congenitally poor development of the macula.
The symptoms of NCMD vary from patient to patient in accordance with the severity of the disease.
- Some patients are asymptomatic, and some patients complain of mildly to moderate central vision loss. In a few patients, there is a marked impairment of central vision typically due to neovascular membrane formation.
- The color vision remains normal.
- There are no systemic manifestations are associated with North Carolina macular dystrophy.
The disease has been divided into three grades according to severity:
- Grade I: there are fine small/intermediate-sized drusen confining to the central 3° of the central macula.
- Grade II: confluent drusen with or without pigmentary changes.
- Grade III: There is well-differentiated chorioretinal atrophy at the macula often surrounding subretinal fibrosis and pigmentation on the edge of the lesion.
Diagnostic Methods
Clinical examination is performed mainly through the fundus examination on slit lamp biomicroscope and indirect ophthalmoscopy.
Other image modalities like fundus fluorescein angiography, Fundus cameras, Electro retinogram, and Electrooculogram fundus provide further details of the disease.
MANAGEMENT of North Carolina Macular Dystrophy
There should be close monitoring for the development of choroidal neovascular membrane formation. If CNVM intravitreal VEGF injections should be prescribed for the management.
The prognosis is very good. In most cases, the patients have stable vision throughout their life.
Would you have interest in taking retina images by smartphone?
Fundus photography is superior to fundus analysis as it enables intraocular pathologies to be photo-captured and encrypted information to be shared with colleagues and patients.
Recent technologies allow smartphone-based attachments and integrated lens adaptors to transform the smartphone into a portable fundus camera and Retinal imaging by smartphone.
RETINAL IMAGING BY YOUR SMARTPHONE
REFERENCES
- Rabb MF, Mullen L, Yelchits S, et al. A North Carolina macular dystrophy phenotype in a Belizean family maps to the MCDR1 locus. Am J Ophthalmol. 1998;125:502e508.
- Small K, Small L, Tran E, Rao R, Shaya F. Multimodal Imaging and Functional Testing in a North Carolina Macular Disease Family: Toxoplasmosis, Fovea Plana, and Torpedo Maculopathy Are Phenocopies. Ophthalmology Retina, Volume 3, Issue 7, 607-614.
- Small KW, Vincent A, Knapper CL, Shaya F. Congenital toxoplasmosis as one phenocopy of North Carolina Macular Dystrophy (NCMD/MCDR1). American Journal of Ophthalmology Case Reports, Volume 15, 2019, 100521.
- Small KW, Agemy S, Shaya FS. Terminology of MCDR1: What’s in a name? JAMA Ophthalmol. 2016;134:355e356.
- Benjamin Bakall, MD, PhD, J. Shepard Bryan III, MD, Edwin M. Stone, MD, PhD, Kent W. Small, MD. Choroidal neovascularization in North Carolina macular dystrophy responsive to anti–vascular endothelial growth factor therapy. Retin Cases Brief Rep. 2018 Oct 31. doi: 10.1097/ICB.0000000000000838. PubMed PMID: 30383557.
RETINAL IMAGING BY YOUR SMARTPHONE
RETINAL IMAGING BY YOUR SMARTPHONE
